Jaguar health presenting march 27 at emerging growth conference and holding investor webcast march 31 regarding q4 2024 financials & near-term catalysts

Click here to register for jaguar's march 27 virtual presentation at the emerging growth conference click here to register for jaguar's march 31 investor webcast company plans to file its annual report on march 31, 2025 on form 10-k for the year ended december 31, 2024 san francisco, ca / access newswire / march 26, 2025 / jaguar health, inc. (nasdaq:jagx) today announced that lisa conte, the company's founder, president and ceo, will present virtually on thursday, march 27, 2025 at the emerging growth conference and that the company will conduct an investor webcast on monday, march 31, 2025 at 8:30 a.m. eastern to review fourth-quarter 2024 financials and provide corporate updates.
JAGX Ratings Summary
JAGX Quant Ranking